title: Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantation.
authors.affiliation: Service d'Hematologie, Purpan Hospital, Toulouse, France.
authors.forename: D
authors.initials: D
authors.lastname: Schlaifer
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: F
authors.initials: F
authors.lastname: Huguet
authors.forename: P
authors.initials: P
authors.lastname: Canal
authors.forename: G
authors.initials: G
authors.lastname: Laurent
authors.forename: J
authors.initials: J
authors.lastname: Pris
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002330:Carmustine / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008942:Mitoxantrone / Q000008:administration & dosage*
chemical_list: D005047:Etoposide; D003520:Cyclophosphamide; D008942:Mitoxantrone; D002330:Carmustine